Press Releases

Thursday, Sep 22, 2016
Press Releases

Over 400 peptides, proteins and antibodies attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions Join us and discuss over 25 presentations and case studies focusing on the key advancements in peptides technologies, chemistry, formulation & delivery as well as peptide therapeutics. See Agenda with speakers…

Thursday, Sep 22, 2016
Press Releases

Over 200 delegates representing internationally renowned research & academic institutions, forensic laboratories, government bodies and sequencing solution providers will be present. Join us and discuss over 40 case studies and presentations focused on future applications of next generation sequencing in forensics, DNA database construction, advances is tools and technologies for…

Press Releases

Medtec China, one stop in the world's leading medical design and manufacturing exhibition and conference series, will be held for the twelfth time this year on 26-28th October at Shanghai World Expo Exhibition & Convention Center. The exhibition is organized by UBM Asia and is dedicated to introducing medical-grade raw…

Press Releases

The ALS Association is pleased to announce MT Pharma America's sponsorship of the Walk to Defeat ALS® , an initiative with over 170 events held every year in communities nationwide. The Walk to Defeat ALS helps to support care service programs, cutting-edge research, and nationwide advocacy efforts for people with…

Press Releases

Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) and Zydus Cadila today announced a partnership to tackle chikungunya, an emerging infectious disease in Africa, Asia and the Indian subcontinent. In recent decades mosquito vectors of chikungunya have spread to Europe and the Americas.i According to the Centers for Disease Control and…

Press Releases

Cure Alzheimer's Fund has announced today that the nonprofit has issued more than $6 million in research grants this year to scientists looking to advance our knowledge of Alzheimer's disease or to develop effective therapies to treat or cure it.  Since the beginning of the year, the organization has funded…

Press Releases

The U.S. Food and Drug Administration today announced the 2016 Naloxone App Competition, a public contest focused on developing innovative technologies to combat the rising epidemic of opioid overdose. The FDA, with support from the National Institute on Drug Abuse (NIDA) and the Substance Abuse and Mental Health Services Administration…

Press Releases

Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), the leading RNAi therapeutics company, announced today two key appointments to its senior leadership team, expanding the breadth of talent and experience as the company prepares for commercialization of its pipeline and global expansion. Dr. Yvonne Greenstreet has joined as Executive Vice President, Chief Operating Officer,…

Press Releases

Pfizer Inc. announced the confirmatory study (REFLECTIONS B537-02) evaluating the efficacy, safety, and immunogenicity of PF-06438179 (infliximab-Pfizer) compared to Remicade® (infliximab) met its primary endpoint. The trial demonstrated equivalent efficacy of the proposed biosimilar PF-06438179 to the originator product as measured by the American College of Rheumatology 20 (ACR20) response…

Press Releases

Ligand Pharmaceuticals Incorporated announces it has entered into a worldwide license agreement with Menlo Park, CA-based TeneoBio, Inc. Under the license, TeneoBio will be able to use the OmniFlic® technology from the OmniAb® platform to discover fully human bispecific antibodies to be developed for the treatment of various diseases, with…